CL2014003317A1 - Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas. - Google Patents

Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas.

Info

Publication number
CL2014003317A1
CL2014003317A1 CL2014003317A CL2014003317A CL2014003317A1 CL 2014003317 A1 CL2014003317 A1 CL 2014003317A1 CL 2014003317 A CL2014003317 A CL 2014003317A CL 2014003317 A CL2014003317 A CL 2014003317A CL 2014003317 A1 CL2014003317 A1 CL 2014003317A1
Authority
CL
Chile
Prior art keywords
tetrahydrothiene
thiazol
dioxo
pyrimidin
difluoro
Prior art date
Application number
CL2014003317A
Other languages
English (en)
Spanish (es)
Inventor
Sukeerthi Kumar
Abraham Thomas
Bipin Parsottam Kansagra
Sukumar Sinha
Sachin Gavhane
Sandeep Bandu Khandagale
Shailesh Pawase
Jayant Prakashrao Patil
Shailendra Bhadane
Bhavna Mishra
Rajesh Dwivedi
Suresh Mahadev Kadam
Original Assignee
Glenmark Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54193746&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014003317(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glenmark Pharmaceuticals Sa filed Critical Glenmark Pharmaceuticals Sa
Publication of CL2014003317A1 publication Critical patent/CL2014003317A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CL2014003317A 2012-06-08 2014-12-04 Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas. CL2014003317A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1687MU2012 2012-06-08
US201261665282P 2012-06-27 2012-06-27
IN3519MU2012 2012-12-13

Publications (1)

Publication Number Publication Date
CL2014003317A1 true CL2014003317A1 (es) 2015-02-13

Family

ID=54193746

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014003317A CL2014003317A1 (es) 2012-06-08 2014-12-04 Sales de n-{4-[2,4-difluoro-3-(trifluorometil)fenil]-1,3-tiazol-2-il}-2-(1,3-dimetil-2,4-dioxo-1,2,3,4-tetrahidrotieno[2,3-d]pirimidin-5-il)acetamida; y procesos para prepararlas.

Country Status (22)

Country Link
US (1) US9458173B2 (enExample)
EP (1) EP2858999B1 (enExample)
JP (1) JP5989900B2 (enExample)
KR (1) KR20150015488A (enExample)
CN (1) CN104350058A (enExample)
AP (1) AP3546A (enExample)
AU (1) AU2013273118B2 (enExample)
BR (1) BR112014029155A2 (enExample)
CA (1) CA2873570C (enExample)
CL (1) CL2014003317A1 (enExample)
EA (1) EA031334B1 (enExample)
HK (1) HK1207643A1 (enExample)
IL (1) IL236084A0 (enExample)
IN (1) IN2014MN02467A (enExample)
MX (1) MX354014B (enExample)
MY (1) MY165622A (enExample)
NZ (1) NZ701721A (enExample)
PE (1) PE20142306A1 (enExample)
PH (1) PH12014502685A1 (enExample)
SG (1) SG11201408093PA (enExample)
WO (1) WO2013183035A2 (enExample)
ZA (1) ZA201500082B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
WO2013185103A1 (en) 2012-06-08 2013-12-12 Gilead Sciences, Inc. Macrocyclic inhibitors of flaviviridae viruses
EP3010489A1 (en) 2013-06-20 2016-04-27 Glenmark Pharmaceuticals S.A. Nanoparticulate formulation comprising a trpa1 antagonist
WO2016023832A1 (en) * 2014-08-11 2016-02-18 Hydra Biosciences, Inc. Thieno- and furo[2,3-d]pyrimidine-2,4[1h,3h]-dione derivatives as trpc5 modulators for the treatment of neuropsychiatric disorders
WO2016042501A1 (en) * 2014-09-16 2016-03-24 Glenmark Pharmaceuticals S.A. Trpa1 antagonist for the treatment of pain associated to diabetic neuropathic pain
TW202321229A (zh) 2021-08-18 2023-06-01 美商富曼西公司 殺真菌的取代的雜環化合物
CN114671875A (zh) * 2022-04-27 2022-06-28 成都施贝康生物医药科技有限公司 新型二氢嘧啶类化合物、异构体或盐及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248231A1 (de) 1972-10-02 1974-04-11 Basf Ag 3-aminoisothiazolo eckige klammer auf 3,4-d eckige klammer zu pyrimidine
SE9701398D0 (sv) 1997-04-15 1997-04-15 Astra Pharma Prod Novel compounds
ES2193839B1 (es) 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
AU2003253165A1 (en) * 2002-08-13 2004-02-25 Warner-Lambert Company Llc Pyrimidine fused bicyclic metalloproteinase inhibitors
US6890923B2 (en) 2002-12-16 2005-05-10 Astrazeneca Ab Compounds
AU2003290066A1 (en) 2002-12-18 2004-07-09 Novartis Ag Anktm1, a cold-activated trp-like channel expressed in nociceptive neurons
WO2005019188A1 (ja) 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited 縮合ピリミジン誘導体およびその用途
WO2005077959A1 (en) 2004-02-11 2005-08-25 Smithkline Beecham Corporation Pth agonists
WO2005089206A2 (en) 2004-03-13 2005-09-29 Irm Llc Modulators of ion channel trpa1
EP1847541A4 (en) 2005-02-03 2009-12-30 Takeda Pharmaceutical CONDENSED PYRIMIDINE DERIVATIVE AND USE THEREOF
CA2617788A1 (en) 2005-08-04 2007-02-15 Apogee Biotechnology Corporation Sphingosine kinase inhibitors and methods of their use
US20070105920A1 (en) 2005-11-08 2007-05-10 Akzo Nobel N.V. 2-(Benzimidazol-1-Yl)-N-(4-phenylthiazol-2-yl) acetamide derivatives
AU2006327181A1 (en) 2005-12-22 2007-06-28 Hydra Biosciences, Inc. TRPA1 inhibitors for treating pain
TW200800997A (en) 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
CN101454318A (zh) * 2006-03-22 2009-06-10 阿斯利康(瑞典)有限公司 吡啶并嘧啶衍生物及其作为pde4抑制剂的用途
JP2011201776A (ja) 2008-07-23 2011-10-13 Mochida Pharmaceut Co Ltd ヘテロシクリデン−n−(3,4−ジヒドロ−2(1h)−キナゾリノン−5−イル)アセトアミド誘導体
CL2008000252A1 (es) 2007-01-29 2008-03-14 Xenon Pharmaceuticals Inc Compuestos derivados de quinazolinona o pirimidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por los canales de calcio, tales como dolor, depresion, enfermedades cardiovasculares, respir
CN101801362B (zh) * 2007-06-22 2014-01-22 海德拉生物科学公司 用于治疗病症的方法和组合物
WO2010004390A1 (en) * 2008-06-17 2010-01-14 Glenmark Pharmaceuticals, S.A. Quinazoline dione derivatives as trpa1 modulators
WO2009158719A2 (en) 2008-06-27 2009-12-30 Hydra Biosciences, Inc. Methods and compositions for treating disorders
BRPI1009372A2 (pt) 2009-03-23 2016-05-31 Glenmark Pharmaceuticals Sa compostos, composição farmacêutica e respectivos usos
US8623880B2 (en) 2009-03-23 2014-01-07 Glenmark Pharmaceuticals S.A. Fused pyrimidine-dione derivatives as TRPA1 modulators
EA023857B1 (ru) 2009-03-23 2016-07-29 Гленмарк Фармасеутикалс С.А. Сочлененные производные пиримидиндионов в качестве модуляторов trpa1
SG174398A1 (en) * 2009-03-23 2011-10-28 Glenmark Pharmaceuticals Sa Furopyrimidinedione derivatives as trpa1 modulators
EP2655377B1 (en) 2010-12-20 2016-03-30 Glenmark Pharmaceuticals S.A. 2-amino-4-arylthiazole compounds as trpa1 antagonists

Also Published As

Publication number Publication date
IL236084A0 (en) 2015-02-01
WO2013183035A2 (en) 2013-12-12
KR20150015488A (ko) 2015-02-10
BR112014029155A2 (pt) 2017-06-27
MX354014B (es) 2018-02-08
JP5989900B2 (ja) 2016-09-07
CA2873570C (en) 2016-11-01
US9458173B2 (en) 2016-10-04
CA2873570A1 (en) 2013-12-12
NZ701721A (en) 2016-03-31
PE20142306A1 (es) 2015-01-16
CN104350058A (zh) 2015-02-11
SG11201408093PA (en) 2015-01-29
AP2014008076A0 (en) 2014-11-30
HK1207643A1 (en) 2016-02-05
PH12014502685B1 (en) 2015-01-26
US20150111038A1 (en) 2015-04-23
EP2858999A2 (en) 2015-04-15
EP2858999B1 (en) 2017-05-10
EA031334B1 (ru) 2018-12-28
AU2013273118A1 (en) 2014-11-27
AP3546A (en) 2016-01-14
ZA201500082B (en) 2015-12-23
AU2013273118B2 (en) 2015-11-05
EA201492054A1 (ru) 2016-08-31
JP2015520183A (ja) 2015-07-16
MX2014014482A (es) 2015-06-05
IN2014MN02467A (enExample) 2015-07-10
WO2013183035A3 (en) 2014-02-27
MY165622A (en) 2018-04-18
PH12014502685A1 (en) 2015-01-26

Similar Documents

Publication Publication Date Title
CY2022003I2 (el) Παραγωγα πυρρολο[2,3-d]πυριμιδινης ως αναστολεις των σχετικων me janus (ιανος) kinασων (jak)
AP3902A (en) Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors
CO6811863A2 (es) Compuestos de 2-(2,4,5-anilino sustituido)pirimidina
CO6801740A2 (es) Inhibidores de quinasa relacionados con pirrolo[2,3-d]pirimidina tropomiosina
IL236495A0 (en) Heteroaromatic compounds as proton tyrosine kinase inhibitors
HUE045957T2 (hu) Proteinkináz inhibitor hatású tieno[3,2-d]pirimidin származékok
HUE037064T2 (hu) Pirrolo[3,2-d]-pirimidin származékok vírusos fertõzések és egyéb betegségek kezelésére
HUE061909T2 (hu) Pirazolo[1,5-a]pirimidinek alkalmazása ATR kináz inhibítorként, rákos megbetegedések kezelésére
EA201492054A1 (ru) Амиды 2-амино-4-арилтиазольных соединений и их соли
CO6910196A2 (es) Derivados de pirrolopirimidina y purina
IL228968A0 (en) Kinase inhibitors pyrazolo [4,3-d]pyrimidine compounds,compositions comprising the same and uses thereof
IL231949A0 (en) [1,2,3] triazolo [4,5,-d] pyrimidmidine derivatives as agonists of the cannabinoid receptor 2
HUE055286T2 (hu) Pirimidinszármazékok vírusfertõzések kezelésére
EP2916836A4 (en) AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
CL2015001530A1 (es) Uso de inhibidores de telomerasa para el tratamiento de desórdenes mieloproliferativos y neoplasias mieloproliferativas
EP2804861A4 (en) Substituted pyrimidine compounds and their use as SYK inhibitors
LT2890680T (lt) N-(3-fluorbenzil-2-(5-(4-morfolinofenil)piridin-2-il)acetamidas, kaip proteintirozinkinazės moduliatorius
EA201591939A1 (ru) ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРА CB2
CL2013002026A1 (es) Compuesto solido (r)-1-etil-3-[5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzimidazol-2-il]-urea y metodo para prepararla.
HRP20150752T1 (xx) Piridinil- i pirazinilmetoksiarilni derivati, korisni kao inhibitori slezenske tirozinske kinaze
HUE037085T2 (hu) Karbamid vegyületek és enzim-inhibitorként történõ alkalmazásuk
EP2754659A4 (en) 4-SUBSTITUTE (3-SUBSTITUTE-1H-PYRAZOLE-5-AMINO) -PYRIMIDIN DERIVATIVE HAVING AN INHIBITORY EFFECT ON PROTEIN KINASE AND USE THEREOF
CO6821957A2 (es) Formas solidas y sales de los derivados de tetrahidro-pirido-pirimidinas
EP2805947A4 (en) PIPERAZINYLPYRIMIDIN DERIVATIVES, METHOD OF MANUFACTURE AND USE THEREOF
EP2922823A4 (en) PDE10 PYRIMIDININHIBITOREN